- Report
- March 2025
- 180 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- April 2024
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 152 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- May 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 196 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Drug Pipelines
- July 2024
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- December 2024
- 70 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- December 2024
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- December 2024
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- December 2024
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- October 2024
- 140 Pages
Global
From €2377EUR$2,500USD£1,997GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more